In addition, EGCG mitigated a cytokine storm in COVID-19 by downregulation of TLR4 and NF-κB and alleviated COVID-19-associated complications, such as sepsis, thrombosis, or lung fibrosis [178]. This evidence concerns the gene NFKB1 and pulmonary fibrosis.